Around 75,000 women in India die each year of cervical cancer. In a significant move to tackle cervical cancer, India will launch an extensive Human Papillomavirus (HPV) vaccination campaign targeting girls in the 9-14 age group. The immunization drive will unfold in three phases, with over seven crore doses prepared for the initial stage. Cervical cancer, currently the second leading cause of cancer among women in India, is poised to become a major focus of the government's immunization program. The WHO ranks cervical cancer as the fourth most common type of cancer globally, emphasizing the urgency of preventive measures. Now how important is this vaccine, and why is it important to address rising cases of cervical cancer in India? Gayathri D Kamath, Senior Consultant - Obstetrics & Gynecology, Fortis Hospital, Bangalore, Dr. Geeta Kadayaprath Senior Surgical Oncologist, Max Hospital, Dr Sarika Gupta, Cervical Cancer Consultant Apollo Hospital discuss.